Foundations Verified Q&A Study Guide (2026/2027) –
100% Pass Guarantee
Section 1: Cellular Pathology & Inflammation
Q1: A patient with chronic gastroesophageal reflux disease (GERD)
develops Barrett’s esophagus. Which cellular adaptation is primarily
responsible for this finding?
A) Dysplasia
B) Hyperplasia
C) Metaplasia
D) Hypertrophy
CORRECT ANSWER>: C) Metaplasia.
Rationale: Metaplasia is the reversible replacement of one mature cell
type with another mature cell type. In Barrett’s esophagus, the normal
stratified squamous epithelium of the esophagus is replaced by
columnar epithelium (goblet cells) to better withstand the acidic
environment.
Q2: During the acute inflammatory response, which cell is the first to
arrive at the site of tissue injury?
A) Lymphocyte
B) Macrophage
C) Eosinophil
,D) Neutrophil
CORRECT ANSWER>: D) Neutrophil.
Rationale: Neutrophils are the predominant leukocytes in the acute
inflammatory response. They are the "first responders" and arrive
within minutes to phagocytize pathogens. Monocytes arrive later and
differentiate into macrophages for sustained cleanup.
Q3: Which chemical mediator causes vascular constriction immediately
after tissue injury, followed by vasodilation and increased vascular
permeability?
A) Histamine
B) Bradykinin
C) Prostaglandin
D) Leukotriene
CORRECT ANSWER>: B) Bradykinin.
Rationale: Bradykinin causes an initial, transient vasoconstriction
immediately following injury, which is then followed by prolonged
vasodilation. Histamine, prostaglandins, and leukotrienes primarily
mediate vasodilation and increased vascular permeability.
Q4: The process of programmed cell death, characterized by chromatin
condensation and cell shrinking without triggering an inflammatory
response, is known as:
A) Necrosis
,B) Apoptosis
C) Pyknosis
D) Infarction
CORRECT ANSWER>: B) Apoptosis.
Rationale: Apoptosis is an active, programmed, energy-dependent
process of cellular self-destruction. Unlike necrosis (which causes cell
swelling, rupture, and inflammation), apoptosis neatly packages cellular
contents into apoptotic bodies for phagocytosis without causing
inflammation.
Section 2: Pharmacokinetics & Pharmacodynamics
Q5: A patient is taking a drug that is a highly protein-bound, weak acid.
If the patient develops metabolic alkalosis, how will the drug's excretion
be affected?
A) Excretion will increase
B) Excretion will decrease
C) Excretion will remain unchanged
D) The drug will become trapped in the tissues
CORRECT ANSWER>: A) Excretion will increase.
Rationale: Weak acids become "trapped" in acidic environments (like
renal tubular urine) and are excreted. In an alkalotic state, the body
compensates by excreting bicarbonate, making the urine more alkaline.
Weak acids will dissociate (ionize) in alkaline urine, become water-
soluble, and be rapidly excreted.
, Q6: Which cytochrome P450 enzyme is responsible for metabolizing the
majority of clinically prescribed drugs, making it a primary site for drug-
drug interactions?
A) CYP1A2
B) CYP2C9
C) CYP2D6
D) CYP3A4
CORRECT ANSWER>: D) CYP3A4.
Rationale: CYP3A4 is the most abundant and clinically significant
enzyme in the liver and intestines, metabolizing approximately 50% of
all marketed drugs. Inhibitors (like ketoconazole or grapefruit juice) can
cause severe drug toxicity.
Q7: A drug that binds to a receptor and produces a maximal cellular
response is classified as a:
A) Partial agonist
B) Full agonist
C) Competitive antagonist
D) Inverse agonist
CORRECT ANSWER>: B) Full agonist.
Rationale: A full agonist has high efficacy and intrinsic activity, meaning
it binds to a receptor and produces the maximum possible biological